The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616]

BMC Medicine

Volumn 3, Issue , 2005, Pages

  van der Horst, Iwan C C ^a,b   Ottervanger, Jan Paul ^b   van't Hof, Arnoud W J ^b   Reiffers, Stoffer ^b   Miedema, Kor ^b   Hoorntje, Jan C A ^b   Dambrink, Jan Henk E ^b   Gosselink, A T Marcel ^b   Nijsten, Maarten W N ^a   Suryapranata, Harry ^b   de Boer, Menko Jan ^b   Zijlstra, Felix ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Isala Klinieken ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; COUMARIN DERIVATIVE; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; GLYCERYL TRINITRATE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MONOCOMPONENT INSULIN; POTASSIUM CHLORIDE; CREATINE KINASE; GLUCOSE INSULIN POTASSIUM CARDIOPLEGIC SOLUTION; GLUCOSE-INSULIN-POTASSIUM CARDIOPLEGIC SOLUTION; INSULIN; POTASSIUM;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG MECHANISM; ENZYME RELEASE; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; DRUG EFFECT; ENZYMOLOGY; HEART INFARCTION; HEART STROKE VOLUME; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CREATINE KINASE; FEMALE; GLUCOSE; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POTASSIUM; PROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 27544482884     PISSN: 17417015     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-3-9     Document Type: Article

References (41)

1. Diaz R. Paolasso EA, Piegas LS, Tajer CD, Moreno MG, Corvalan R, Isea JE, Romero G: Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 1998, 98:2227-2234.
2. Fath-Ordoubadi F, Beatt KJ: Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 1997, 96:1152-1156,
3. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L: Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995, 26:57-65.
4. van der Horst IC, Zijlstra F, van't Hof AW, Doggen CJ, de Boer MJ, Suryapranata H, Hoorntje JC, Dambrink JH, Gans RO, Bilo HJ: Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. J Am Coll Cardiol 2003, 42:784-791.
5. Bellows SD, Kloner KA: Glucose-Insulin-Potassium Does Not Reduce Myocardial Infarct Size in an Ischemic/Reperfusion Rabbit Model. J Thromb Thrombolysis 1998, 5:25-27.
6. Chauduri A, Janicke D, Wilson MF, Tripathy D, Garg R, Bandyopadhyay A, Calieri J, Hoffmeyer D, Syed T, Ghanim H, Aljada A, Dandona P: Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 2004, 109:849-854.
7. Dalby AJ, Bricknell OL, Opie LH: Effect of glucose-insulin-potassium infusions on epicardial ECG changes and on myocardial metabolic changes after coronary artery ligation in dogs. Cardiovasc Res 1981, 15:588-598.
8. Heng MK, Norris RM, Singh BN, Barratt-Boyes C: Effects of glucose and glucose-insulin-potassium on haemodynamics and enzyme release after acute myocardial Infarction. Br Heart J 1977, 39:748-757.
9. Heng MK, Norris RM, Peter T, Nisbet HD, Singh BN: The effect of glucose-insulin-potassium on experimental myocardial infarction in the dog. Cardiovasc Res 1978, 12:429-435.
10. Jonassen AK, Aasum E, Riemersma RA, Mjos OD, Larsen TS: Glucose-insulin-potassium reduces infarct size when administered during reperfusion. Cardiovasc Drugs Ther 2000, 14:615-623.
11. Maroko PR, Libby P, Sobel BE, Bloor CM, Sybers HD, Shell WE, Covell JW, Braunwald E: Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circulation 1972, 45:1160-1175.
12. Reduto L, Gullota S, Morisson M: Effects of glucose-insulin-potassium infusion on ischemic myocardium. Clinical Research 1974, 22:685A.
13. Rogers WJ, Segall PH, McDaniel HG, Mantle JA, Russell RO Jr, Rackley CE: Prospective randomized trial of glucose-insulin-potassium in acute myocardial infarction. Effects on myocardial hemodynamics, substrates and rhythm. Am J Cardiol 1979, 43:801-809.
14. Sundstedt CD, Sylven C, Mogensen L: Glucose-insulin-potassium-albumin infusion in the early phase of acute myocardial infarction - a controlled study. Acta Med Stand 1981, 210:67-71.
15. Whitlow PL, Rogers WJ, Smith LR, McDaniel HG, Papapietro SE, Mantle JA, Logic JR, Russell RO Jr, Rackley CE: Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction. Am J Cardiol 1982, 49:811-820.
16. Zhu P, Lu L, Xu Y, Greyson C, Schwartz GG: Glucose-insulin-potassium preserves systolic and diastolic function in ischemia and reperfusion in pigs. Am J Physiol Heart Circ Physiol 2000, 278:H595-H603.
17. Satler LF, Green CE, Kent KM, Pallas RS, Pearle DL, Rackley CE: Metabolic support during coronary reperfusion. Am Heart J 1987, 114:54-58.
18. Castro PF, Larrain G, Baeza R, Corbalan R, Nazzal C, Greig DP, Miranda FP, Perez O, Acevedo M, Marchant E, Olea E, Gonzalez R: Effects of glucose-insulin-potassium solution on myocardial salvage and left ventricular function after primary angioplasty. Crit Care Med 2003, 31:2152-2155.
19. Ceremuzynski L, Budaj A, Czepiel A, Burzykowski T, Achremczyk P, Smielak-Korombel W. Maciejewicz J. Dziubinska J, Nartowicz E, Kawka-Urbanek T, Piotrowski W, Hanzlik J. Cieslinski A, Kawecka-Jaszcz K, Gessek J, Wrabec K: Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial. Cardiovasc Drugs Ther 1999, 13:191-200.
20. Pache J, Kastrati A, Mehilli J, Bollwein H, Ndrepepa G, Schuhlen H, Martinoff S, Seyfarth M, Nekolla S, Dirschinger J, Schwaiger M, Schomig A: A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy. Am Heart J 2004, 148:105.
21. McGowan JH, Cleland JG: Reliability of reporting left ventricular systolic function by echocardiography: a systematic review of 3 methods. Am Heart J 2003, 146:388-397.
22. Henriques JP, Zijlstra F, van't Hof AW, de Boer MJ, Dambrink JH, Gosselink M, Hoorntje JC, Suryapranata H: Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation 2003, 107:2115-2119.
23. Ottervanger JP, van't Hof AW, Reiffers S, Hoorntje JC, Suryapranata H, de Boer MJ, Zijlstra F: Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur Heart J 2001, 22:785-790.
24. Sasso FC, Carbonara O, Cozzolino D, Rambaldi P, Mansi L, Torella D, Gentile S, Turco S, Torella R, Salvatore T: Effects of insulin-glucose infusion on left ventricular function at rest and during dynamic exercise in healthy subjects and noninsulin dependent diabetic patients: a radionuclide ventriculographic study. J Am Coll Cardiol 2000, 36:219-226.
25. Yetkin E, Senen K, Ileri M, Atak R, Tandogan I, Yetkin O, Kosar F, Turhan H, Cehreli S: Comparison of low-dose dobutamine stress echocardiography and echocardiography during glucose-insulin-potassium infusion for detection of myocardial viability after anterior myocardial infarction. Coron Artery Dis 2002, 13:145-149.
26. Mehta SR, Yusuf S, Diaz R, Zhu J, Pais P, Xavier O, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L: Effect of glucose-insulin-patassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005, 293:437-446.
27. Ramanathan T, Shirota K, Morita S, Nishimura T, Huang Y, Hunyor SN: Glucose-insulin-potassium solution improves left ventricular mechanics in diabetes. Ann Thorac Surg 2002, 73:582-587.
28. Apstein CS, Gravino FN, Haudenschild CC: Determinants of a protective effect of glucose and insulin on the ischemic myocardium. Effects on contractile function, diastolic compliance, metabolism and ultrastructure during ischemia and reperfusion. Circ Res 1983, 52:515-526.
29. Depre C, Vanoverschelde JL, Taegtmeyer H: Glucose for the heart. Circulation 1999, 99:578-588.
30. Opie LH: The glucose hypothesis: its relation to acute myocardial ischemia. J Mol Cell Cardiol 1970, 1:107-115.
31. Rackley CE, Russell RO Jr, Rogers WJ, Mantle JA, McDaniel HG, Papapietro SE: Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction. Am Heart J 1981, 102:1038-1049.
32. Lopaschuk GD, Wambolt RB, Barr RL: An Imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J Pharmacol Exp Ther 1993, 264:135-144.
33. Eberli FR, Weinberg EO, Grice WN, Horowitz GL, Apstein CS: Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions. Circ Rec 1991, 68:466-481.
34. McNulty PH, Pfau S, Deckelbaum LI: Effect of plasma insulin level on myocardial blood flow and its mechanism of action. Am J Cardiol 2000, 85:161-165.
35. Sundell J, Laine H, Nuutila P, Ronnemaa T, Luotolahti M, Raitakari O, Knuuti J: The effects of insulin and short-term hyperglycaemia on myocaudial blood flow in young men with uncomplicated Type I diabetes. Diabetologia 2002, 45:775-782.
36. Marano L, Bestetti A, Lomuscio A, Tagliabue L, Castini D, Tarricone D, Dario P, Tarolo GL, Fiorentini C: Effects of infusion of glucose-insulin-potassium on myocardial function after a recent myocardial infarction. Acta Cardiol 2000, 55:9-15.
37. Aikawa R, Nawano M, Gu Y, Katagiri H, Asano T, Zhu W, Nagai R, Komuro I: Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of P13 kinase/Akt. Circulation 2000, 102:2873-2879.
38. Jonassen AK, Sack MN, Mjos OD, Yellon DM: Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 2001, 89:1191-1198.
39. Matsui T, Tao J, del Monte F, Lee KH, Li L, Picard M, Force TL, Franke TF, Hajjar RJ, Rosenzweig A: Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 2001, 104:330-335.
40. Sack MN, Yellon DM: Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation. J Am Coll Cardiol 2003, 41:1404-1407.
41. Diaz-Araya G, Nettle D, Castro P, Miranda F, Greig D, Campos X, Chiong M, Nazzal C, Corbalan R, Layandero S: Oxidative stress after reperfusion with primary coronary angioplasty: lack of effect of glucose-insulin-potassium infusion. Crit Care Med 2002, 30:417-421.